glp 1 telehealth The GLP-1 Boom: Innovation or Privacy Nightmare? GLP-1 Weight Loss Therapy |
Description
88 , 220224 (2003) Kabsch, W
doi: 10.3390/nu11122907
Verify the current compounding status of LIV Body's named pharmacy providers directly with the platform before enrolling
While the study found that semaglutide specifically reduced the risk of atrial arrhythmias and atrial fibrillation (AF), other studies have reported conflicting results regarding the arrhythmia risk associated with GLP-1 RAs (91)
